Insider Sale: Director at $NTRA (NTRA) Sells 2,100 Shares
Insider Sale: Director at $NTRA (NTRA) Sells 2,100 Shares
Gail Boxer Marcus, a director at $NTRA ($NTRA), sold 2,100 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.8% of their shares. Following this trade, they now own 9,704 shares of $NTRA stock.
盖尔·博克萨·马库斯,$NTRA ($NTRA) 的董事,于2024年11月19日出售了2100股该公司的股票。我们从最近的SEC备案中获得了交易数据。这是他们股份大约17.8%的出售。在此次交易后,他们目前拥有$NTRA 股票9704股。
$NTRA Insider Trading Activity
$NTRA 内部交易活动
$NTRA insiders have traded $NTRA stock on the open market 115 times in the past 6 months. Of those trades, 0 have been purchases and 115 have been sales.
$NTRA 内部人过去6个月在公开市场上交易了115次$NTRA股票。在这些交易中,没有购买,115次为出售。
Here's a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
以下是过去6个月内部人交易$NTRA股票的详细信息:
- GAIL BOXER MARCUS has traded it 8 times. They made 0 purchases and 8 sales, selling 13,894 shares.
- ROY D. BAYNES has traded it 6 times. They made 0 purchases and 6 sales, selling 37,230 shares.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has traded it 27 times. They made 0 purchases and 27 sales, selling 82,243 shares.
- JONATHAN SHEENA has traded it 37 times. They made 0 purchases and 37 sales, selling 89,800 shares.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has traded it 16 times. They made 0 purchases and 16 sales, selling 19,025 shares.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has traded it 7 times. They made 0 purchases and 7 sales, selling 8,342 shares.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has traded it 6 times. They made 0 purchases and 6 sales, selling 5,138 shares.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has traded it 6 times. They made 0 purchases and 6 sales, selling 6,468 shares.
- ROWAN E CHAPMAN has traded it 2 times. They made 0 purchases and 2 sales, selling 7,470 shares.
- 盖尔·博克萨·马库斯交易了8次。他们没有购买,而是进行了8次出售,卖出了13894股。
- 罗伊·D·贝因斯交易了6次。他们没有购买,而是进行了6次出售,卖出了37230股。
- 史蒂文·伦纳德·查普曼(首席执行官和总裁)交易了27次。他们没有购买,而是进行了27次出售,卖出了82243股。
- 乔纳森·希纳交易了37次。他们没有购买,而是进行了37次出售,卖出了89800股。
- 迈克尔·伯克斯·布罗菲(首席财务官)已交易16次。他们没有购买,进行了16次出售,总共出售了19,025股。
- 约翰·费斯科(总裁,首席业务官)已交易7次。他们没有购买,进行了7次出售,总共出售了8,342股。
- 所罗门·莫什凯维奇(总裁,临床诊断)已交易6次。他们没有购买,进行了6次出售,总共出售了5,138股。
- 丹尼尔·拉比诺维茨(秘书及首席法律官)已交易6次。他们没有购买,进行了6次出售,总共出售了6,468股。
- 罗万·E·查普曼已交易2次。他们没有购买,进行了2次出售,总共出售了7,470股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易,请查看Quiver Quantitative的内部交易特斯拉-仪表。
$NTRA Hedge Fund Activity
$NTRA对冲基金活动
We have seen 242 institutional investors add shares of $NTRA stock to their portfolio, and 259 decrease their positions in their most recent quarter.
我们看到242名机构投资者在最近一个季度将$NTRA股票添加到他们的投资组合中,259名减少了他们的持仓。
Here are some of the largest recent moves:
以下是一些最近最大的交易动态:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,341,756 shares (+442.8%) to their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP added 1,883,481 shares (+205.4%) to their portfolio in Q3 2024
- DUQUESNE FAMILY OFFICE LLC added 1,591,970 shares (+80.6%) to their portfolio in Q3 2024
- BLACKROCK, INC. added 1,461,550 shares (+21.6%) to their portfolio in Q3 2024
- JPMORGAN CHASE & CO removed 1,433,790 shares (-23.6%) from their portfolio in Q3 2024
- FRED ALGER MANAGEMENT, LLC removed 1,250,664 shares (-23.8%) from their portfolio in Q3 2024
- AMERIPRISE FINANCIAL INC removed 861,463 shares (-26.0%) from their portfolio in Q3 2024
- PRICE T ROWE ASSOCIATES INC /MD/ 在2024年第三季度向其投资组合中添加了2,341,756股 (+442.8%)
- WELLINGTON MANAGEMENt GROUP LLP 在2024年第三季度向其投资组合中添加了1,883,481股 (+205.4%)
- DUQUESNE FAMILY OFFICE LLC 在2024年第三季度向其投资组合中添加了1,591,970股 (+80.6%)
- BLACKROCk, INC. 在2024年第三季度向其投资组合中添加了1,461,550股 (+21.6%)
- JPMORGAN CHASE & CO 在2024年第三季度从其投资组合中移除了1,433,790股 (-23.6%)
- FRED ALGER MANAGEMENt, LLC 在2024年第三季度从其投资组合中移除了1,250,664股 (-23.8%)
- AMERIPRISE FINANCIAL INC 在2024年第三季度从其投资组合中移除了861,463股 (-26.0%)
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追踪对冲基金的股票组合,请查看Quiver Quantitative的机构持股仪表板。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不构成金融建议。有关Quiver Quantitative的免责声明,请查看更多信息。